Antigen Delivery Articles & Analysis
3 news found
But the timeline for the development of some vaccine types is still grueling, spanning preclinical design, multiple trial phases, and complex manufacturing hurdles. With challenges like antigen selection, delivery optimization, and large-scale production, companies like Creative Biolabs are rare and indispensable partners for pharma and academic groups racing ...
By keeping up with the latest advancements in the field, its team of expert scientists possesses a deep knowledge of RNA biology, viral vectors, antigen design, and delivery systems. This expertise allows them to design and develop highly effective and safe mRNA vaccine candidates. ...
The first of two manuscripts has been published in "NPJ Vaccines" and provides data demonstrating that the company’s structure-guided antigen design and synthetic nanoparticle delivery platform has been used to generate a candidate vaccine (V-306) for prophylaxis against RSV infection. ...